CN113684152A - Bacteria preservation culture medium and preparation method thereof - Google Patents
Bacteria preservation culture medium and preparation method thereof Download PDFInfo
- Publication number
- CN113684152A CN113684152A CN202111002913.3A CN202111002913A CN113684152A CN 113684152 A CN113684152 A CN 113684152A CN 202111002913 A CN202111002913 A CN 202111002913A CN 113684152 A CN113684152 A CN 113684152A
- Authority
- CN
- China
- Prior art keywords
- extract powder
- bacteria
- maozolone
- cycloserine
- agar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to the technical field of strain preservation, in particular to a bacterium preservation culture medium and a preparation method thereof. The culture medium comprises the following components: contains, in 1000 ml: 8-13g of beef extract, 2-6g of peptone, 0.2-0.5g of bile salt, 0.2-0.3g of aluminum potassium sulfate, 2-5g of malt extract powder, 3-7g of yeast extract powder, 0.3-0.6g of sodium chloride, 5-10g of agar, 0.2-0.5g of soluble iron salt, 0.01-0.05g of calcium supplement, 0.02-0.05g of D-cycloserine, 0.001-0.004g of maozolone, 10.01-0.02g of vitamin K, 0.1-0.3g of complex protein phosphopeptide, 3-5g of glucose, 1-2.5g of lanthanum nitrate, 3-5g of erythritol, 18-23ml of glycerol, 0.1-0.2mg of warfarin sodium tablet, 8-12mg of isoniazide and 75-85ml of aseptic defibrinated sheep blood. The nutrient substances in the formula are rich and comprehensive, the survival of the strains can be ensured, and even if the preservation environment temperature is greatly changed, the culture medium can still ensure the effectiveness of the strains.
Description
Technical Field
The invention relates to the technical field of strain preservation, in particular to a bacterium preservation culture medium and a preparation method thereof.
Background
Bacteria are one of the major biological resources and are frequently used in medical experiments. After a good strain is selected and bred, the good property of the strain must be kept unchanged or slowly changed as little as possible, so that the performance of the strain is not reduced, and the strain can be applied in production for a long time. The strain preservation method has a plurality of methods, the cryopreservation is an effective way for solving the germplasm degradation and preventing the naturally accumulated mutation, but the traditional cryopreservation needs expensive program cooling instruments and has complicated steps. Complete vitrification is a new method for low-temperature preservation, namely, under the condition of high-concentration protective agent, the cells and the protective agent are all in a vitrification state in the process of rapid cooling, the formation of ice crystals in cells is avoided, and all parts of organs and tissues are all in the same state.
In the prior art, the use amount of agar in the bacteria preservation culture medium is large, the restriction effect on strains is poor, the activity of the strains is reduced after preservation, and the long-term preservation of the strains is not facilitated.
Disclosure of Invention
Based on the above problems, the present invention provides a bacteria preservation medium and a method for preparing the same, which can improve the activity in the preservation of strains. The specific technical scheme is as follows:
a bacteria preservation medium comprises the following components:
contains, in 1000 ml: 8-13g of beef extract, 2-6g of peptone, 0.2-0.5g of bile salt, 0.2-0.3g of aluminum potassium sulfate, 2-5g of malt extract powder, 3-7g of yeast extract powder, 0.3-0.6g of sodium chloride, 5-10g of agar, 0.2-0.5g of soluble iron salt, 0.01-0.05g of calcium supplement, 0.02-0.05g of D-cycloserine, 0.001-0.004g of maozolone, 10.01-0.02g of vitamin K, 0.1-0.3g of complex protein phosphopeptide, 3-5g of glucose, 1-2.5g of lanthanum nitrate, 3-5g of erythritol, 18-23ml of glycerol, 0.1-0.2mg of warfarin sodium tablet, 8-12mg of isoniazide and 75-85ml of aseptic defibrinated sheep blood.
Preferably, the bacteria preservation medium comprises the following components:
in 1000 ml: 10g of beef extract, 5g of peptone, 0.3g of bile salt, 0.25g of potassium aluminum sulfate, 4g of malt extract powder, 5g of yeast extract powder, 0.5g of sodium chloride, 8g of agar, 0.3g of ferric citrate, 0.03g of calcium lactate, 0.03g of D-cycloserine, 0.003g of maozolone, 10.01g of vitamin K, 0.1g of complexing protein phosphopeptide, 5g of glucose, 2g of lanthanum nitrate, 4g of erythritol, 20ml of glycerol, 0.1mg of warfarin sodium tablets, 10mg of isoniazide, 80ml of sterile defibrinated sheep blood, and distilled water added to 1000 ml.
Specifically, the soluble ferric salt is ferric ammonium citrate.
Specifically, the calcium supplement is calcium lactate.
The preparation method of the bacteria preservation culture medium comprises the following steps:
(1) according to the raw material proportion, taking beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride, agar, soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazid and sterile defibrinated sheep blood for later use;
(2) uniformly mixing beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride and agar, pouring soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazide and sterile defibrinated sheep blood, adding distilled water to 1000ml, and heating to 50-60 ℃ to dissolve all substances;
(3) sterilizing the above solutions, and subpackaging in culture vessels for cooling.
Specifically, the sterilization condition is that the temperature is 130-150 ℃ and the time is 3-5 h.
Specifically, the culture vessel is any one of a test tube or a culture vessel.
Specifically, the refrigeration temperature is 2-4 ℃.
Compared with the prior art, the invention has the beneficial effects that:
the formula of the invention contains peptone, bile salt, potassium aluminum sulfate, malt extract powder, yeast extract powder, sodium chloride, agar, ferric ammonia, calcium lactate, D-cycloserine, maozolone, vitamins, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol and distilled water, and the nutrient substances are rich and comprehensive. The contained components of ferric citrate, calcium lactate, complex protein phosphopeptide, glucose, vitamin, lanthanum nitrate and the like can ensure the survival of strains. Wherein, the bile salt, D-cycloserine, maozolone and other substances have the function of inhibiting the growth of bacteria and are beneficial to the long-term survival of the bacteria. The warfarin sodium tablet and isoniazid can reduce the metabolism of bacteria and inhibit the growth of bacteria. Erythritol, glycerol and other substances have the moisturizing effect and meet the requirement of sufficient water content of the culture medium. The agar powder has low content, is semisolid in culture medium, and is beneficial for bacteria preservation. When the culture medium is used for preserving bacteria, the growth period of the bacteria is slow, mixed bacteria can not grow, the activity of the bacteria can be kept and the bacteria can not die easily, and even if the preservation environment is changed greatly, the culture medium can still ensure the effectiveness of the strains. The culture medium has simple preparation equipment, low cost and high practical value.
Detailed Description
Example 1:
a bacteria preservation medium comprises the following components:
contains, in 1000 ml: 8g of beef extract, 2g of peptone, 0.2g of bile salt, 0.2g of potassium aluminum sulfate, 2g of malt extract powder, 3g of yeast extract powder, 0.3g of sodium chloride, 5g of agar, 0.2g of soluble ferric salt, 0.01g of calcium supplement, 0.02g of D-cycloserine, 0.001g of maozolone, 10.01g of vitamin K, 0.1g of complex protein phosphopeptide, 3g of glucose, 1g of lanthanum nitrate, 3g of erythritol, 18ml of glycerol, 0.1mg of warfarin sodium tablets, 8mg of isoniazide and 75ml of sterile defibrinated sheep blood; the soluble ferric salt is ferric ammonium citrate; the calcium supplement is calcium lactate.
The bacteria preservation medium described in this example was prepared as follows:
(1) according to the raw material proportion, taking beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride, agar, soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazid and sterile defibrinated sheep blood for later use;
(2) uniformly mixing beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride and agar, pouring soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazide and sterile defibrinated sheep blood, adding distilled water to 1000ml, and heating to 50 ℃ to dissolve all substances;
(3) sterilizing the solution, and subpackaging in culture vessels for cooling for later use; the sterilization condition is that the temperature is 130 ℃ and the time is 3 h; the culture vessel is a test tube; the refrigeration temperature is 2 ℃.
Example 2
A bacteria preservation medium comprises the following components:
in 1000 ml: 10g of beef extract, 5g of peptone, 0.3g of bile salt, 0.25g of potassium aluminum sulfate, 4g of malt extract powder, 5g of yeast extract powder, 0.5g of sodium chloride, 8g of agar, 0.3g of ferric citrate, 0.03g of calcium lactate, 0.03g of D-cycloserine, 0.003g of maozolone, 10.01g of vitamin K, 0.1g of complexing protein phosphopeptide, 5g of glucose, 2g of lanthanum nitrate, 4g of erythritol, 20ml of glycerol, 0.1mg of warfarin sodium tablets, 10mg of isoniazide, 80ml of sterile defibrinated sheep blood, and distilled water added to 1000 ml.
The bacteria preservation medium described in this example was prepared as follows:
(1) according to the raw material proportion, taking beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride, agar, soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazid and sterile defibrinated sheep blood for later use;
(2) uniformly mixing beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride and agar, pouring soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazide and sterile defibrinated sheep blood, adding distilled water to 1000ml, and heating to 55 ℃ to dissolve all substances;
(3) sterilizing the solution, and subpackaging in culture vessels for cooling for later use; the sterilization condition is that the temperature is 140 ℃ and the time is 4 hours; the culture vessel is a test tube; the refrigeration temperature is 3 ℃.
Example 3
A bacteria preservation medium comprises the following components:
contains, in 1000 ml: 13g of beef extract, 6g of peptone, 0.5g of bile salt, 0.3g of aluminum potassium sulfate, 5g of malt extract powder, 7g of yeast extract powder, 0.6g of sodium chloride, 10g of agar, 0.5g of soluble ferric salt, 0.05g of calcium supplement, 0.05g of D-cycloserine, 0.004g of maozolone, 10.02g of vitamin, 0.3g of complexing protein phosphopeptide, 5g of glucose, 2.5g of lanthanum nitrate, 5g of erythritol, 23ml of glycerol, 0.2mg of warfarin sodium tablets, 12mg of isoniazide and 85ml of sterile defibrinated sheep blood; the soluble ferric salt is ferric ammonium citrate; the calcium supplement is calcium lactate.
The bacteria preservation medium described in this example was prepared as follows:
(1) according to the raw material proportion, taking beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride, agar, soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazid and sterile defibrinated sheep blood for later use;
(2) uniformly mixing beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride and agar, pouring soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazide and sterile defibrinated sheep blood, adding distilled water to 1000ml, and heating to 60 ℃ to dissolve all substances;
(3) sterilizing the solution, and subpackaging in culture vessels for cooling for later use; the sterilization condition is that the temperature is 150 ℃ and the time is 5 h; the culture vessel is a culture vessel; the refrigeration temperature was 4 ℃.
To verify the inventive scheme, the following comparative examples were set up:
| comparative example 1 | The difference from example 1 is that maozolone is not used in the manufacturing raw material; |
| comparative example 2 | The difference from the embodiment 1 is that the ferric ammonium citrate is not used in the preparation raw material; |
| comparative example 3 | The difference from example 1 is that lanthanum nitrate is not used in the preparation raw material; |
| comparative example 4 | The difference from example 1 is that D-cycloserine was not used in the starting material; |
| comparative example 5 | The difference from example 1 is that isoniazid was not used as a starting material. |
Test examples
Respectively preparing culture media according to examples 1-3 and comparative examples 1-5, pouring the culture media into culture dishes in an aseptic environment, adding 2ml of bacterial liquid into each culture dish, and storing in a refrigerator at minus 50 ℃; the test strains are respectively staphylococcus aureus, escherichia coli and proteus, the culture dish inoculated by each bacterium is independently preserved, and the recovery is carried out after 5 months and 10 months of preservation, and the activity of the bacteria is counted.
When the strains are revived, hot water with the temperature of 35 ℃ is selected for heating and unfreezing in water bath, the most suitable culture medium of each strain is selected for culture, and the revival quantity is counted.
The test results are shown in the following table.
As can be seen from the table, the bacteria preservation effect of the bacteria preservation medium of the embodiment 1-3 is excellent, the preservation survival rate of the staphylococcus aureus, the escherichia coli and the proteus can reach 100% within five months, the preservation time is prolonged to 1 month, the survival rate of the staphylococcus aureus can reach more than 98.94%, the survival rate of the escherichia coli can reach more than 98.41%, and the survival rate of the proteus can reach more than 98.31%, so that the remarkable effect of the bacteria preservation effect of the medium is achieved.
The above refrigeration operation of the bacteria was repeated in a refrigerator at a refrigeration temperature of-30 ℃ to count the survival rates of the bacteria after 5 months and 10 months of refrigeration.
The test results are shown in the following table.
As can be seen from the table, when the bacteria were preserved using the culture media of examples 1 to 3 of the present invention, the survival rate of Staphylococcus aureus was more than 99.50%, the survival rate of Escherichia coli was more than 99.70%, and the survival rate of Proteus bacteria was more than 99.65% in the 5-month preservation; the survival rate of staphylococcus aureus exceeds 96.50 percent, the survival rate of escherichia coli exceeds 96.81 percent and the survival rate of proteus bacteria exceeds 96.62 percent in the preservation of 10 months. The culture medium prepared by the method can ensure the activity of the strains even under the condition that the strain preservation temperature is increased, and if the preservation equipment has problems in actual use and causes great change of the environment, the method can still ensure the effectiveness of the strains, and the practical value is obvious.
Claims (8)
1. A bacteria preservation medium is characterized by comprising the following components:
contains, in 1000 ml: 8-13g of beef extract, 2-6g of peptone, 0.2-0.5g of bile salt, 0.2-0.3g of aluminum potassium sulfate, 2-5g of malt extract powder, 3-7g of yeast extract powder, 0.3-0.6g of sodium chloride, 5-10g of agar, 0.2-0.5g of soluble iron salt, 0.01-0.05g of calcium supplement, 0.02-0.05g of D-cycloserine, 0.001-0.004g of maozolone, 10.01-0.02g of vitamin K, 0.1-0.3g of complex protein phosphopeptide, 3-5g of glucose, 1-2.5g of lanthanum nitrate, 3-5g of erythritol, 18-23ml of glycerol, 0.1-0.2mg of warfarin sodium tablet, 8-12mg of isoniazide and 75-85ml of aseptic defibrinated sheep blood.
2. A bacterial preservation medium according to claim 1, comprising the following components:
in 1000 ml: 10g of beef extract, 5g of peptone, 0.3g of bile salt, 0.25g of potassium aluminum sulfate, 4g of malt extract powder, 5g of yeast extract powder, 0.5g of sodium chloride, 8g of agar, 0.3g of ferric citrate, 0.03g of calcium lactate, 0.03g of D-cycloserine, 0.003g of maozolone, 10.01g of vitamin K, 0.1g of complexing protein phosphopeptide, 5g of glucose, 2g of lanthanum nitrate, 4g of erythritol, 20ml of glycerol, 0.1mg of warfarin sodium tablets, 10mg of isoniazide, 80ml of sterile defibrinated sheep blood, and distilled water added to 1000 ml.
3. The bacteria preservation medium of claim 1, wherein the soluble iron salt is ferric ammonium citrate.
4. A preservation medium according to claim 1, wherein said calcium supplement is calcium lactate.
5. A preservation medium for bacteria according to claim 1, prepared by the following method:
(1) according to the raw material proportion, taking beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride, agar, soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazid and sterile defibrinated sheep blood for later use;
(2) uniformly mixing beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride and agar, pouring soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazide and sterile defibrinated sheep blood, adding distilled water to 1000ml, and heating to 50-60 ℃ to dissolve all substances;
(3) sterilizing the above solutions, and subpackaging in culture vessels for cooling.
6. The bacteria preservation medium according to claim 5, wherein the sterilization conditions are a temperature of 130 ℃ and a temperature of 150 ℃ for a period of 3-5 h.
7. A bacteria preservation medium according to claim 5, wherein said culture vessel is any one of a test tube or a culture dish.
8. A preservation medium for bacteria according to claim 5, wherein the refrigeration temperature is 2-4 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111002913.3A CN113684152A (en) | 2021-08-30 | 2021-08-30 | Bacteria preservation culture medium and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111002913.3A CN113684152A (en) | 2021-08-30 | 2021-08-30 | Bacteria preservation culture medium and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113684152A true CN113684152A (en) | 2021-11-23 |
Family
ID=78583977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111002913.3A Pending CN113684152A (en) | 2021-08-30 | 2021-08-30 | Bacteria preservation culture medium and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113684152A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113150995A (en) * | 2021-04-22 | 2021-07-23 | 贵州安康医学检验中心有限公司 | Bacterium transferring and preserving culture medium used in transferring process and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101089191A (en) * | 2006-06-16 | 2007-12-19 | 阚方琦 | Enriched medium for blood sampler typhoid bacillus |
| CN103497192A (en) * | 2008-12-09 | 2014-01-08 | 吉里德科学公司 | Modulators of TOLL-like receptors |
| CN104284984A (en) * | 2012-02-29 | 2015-01-14 | 哈佛大学校长及研究员协会 | Rapid antibiotic susceptibility testing |
| CN108348776A (en) * | 2015-06-30 | 2018-07-31 | 健康研究公司 | The diagnostic check that Alzheimer disease is carried out based on measurement proteolysis access |
| CN110558358A (en) * | 2019-08-27 | 2019-12-13 | 江门职业技术学院 | Mung bean and broom corn millet biscuits and preparation method thereof |
| CN113150995A (en) * | 2021-04-22 | 2021-07-23 | 贵州安康医学检验中心有限公司 | Bacterium transferring and preserving culture medium used in transferring process and preparation method thereof |
-
2021
- 2021-08-30 CN CN202111002913.3A patent/CN113684152A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101089191A (en) * | 2006-06-16 | 2007-12-19 | 阚方琦 | Enriched medium for blood sampler typhoid bacillus |
| CN103497192A (en) * | 2008-12-09 | 2014-01-08 | 吉里德科学公司 | Modulators of TOLL-like receptors |
| CN104284984A (en) * | 2012-02-29 | 2015-01-14 | 哈佛大学校长及研究员协会 | Rapid antibiotic susceptibility testing |
| CN108348776A (en) * | 2015-06-30 | 2018-07-31 | 健康研究公司 | The diagnostic check that Alzheimer disease is carried out based on measurement proteolysis access |
| CN110558358A (en) * | 2019-08-27 | 2019-12-13 | 江门职业技术学院 | Mung bean and broom corn millet biscuits and preparation method thereof |
| CN113150995A (en) * | 2021-04-22 | 2021-07-23 | 贵州安康医学检验中心有限公司 | Bacterium transferring and preserving culture medium used in transferring process and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| JUANJUAN YANG等: "《Biophysical characterization and ligand-bindingproperties of the elongation factor Tu fromMycobacterium tuberculosis》", 《ACTA BIOCHIM BIOPHYS SIN (SHANGHAI)》 * |
| 李振林主编: "《微生物学及检验技术》", 31 July 1994, 广东科技出版社 * |
| 谢晖主编: "《现代工科微生物学实验教程》", 31 August 2019, 西安交通大学出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113150995A (en) * | 2021-04-22 | 2021-07-23 | 贵州安康医学检验中心有限公司 | Bacterium transferring and preserving culture medium used in transferring process and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20060078872A1 (en) | Cell-preservation liquid | |
| CN102643749B (en) | Microorganism low-temperature preservation protective agent and microorganism low-temperature preservation method | |
| CN107217020B (en) | Culture medium suitable for lactobacillus acidophilus and preparation method thereof | |
| CN113684152A (en) | Bacteria preservation culture medium and preparation method thereof | |
| CN100548129C (en) | A kind of multi-functional antistaling agent for fruits and vegetables | |
| CN112251371A (en) | Lactococcus lactis, microecological preparation and application | |
| Ward et al. | The preservation of gonococci in liquid nitrogen | |
| CN115478017B (en) | Cryoprotectant for improving activity of lactobacillus bulgaricus, and freezing method and application thereof | |
| CN103039438A (en) | Fresh flower preservative containing marine biological components | |
| CN111685102A (en) | Sheep sperm solution diluent powder | |
| CN107698400B (en) | Composite iron supplement agent suitable for saline-alkali soil and preparation and use methods thereof | |
| CN107232184B (en) | Diluent for preserving semen of black pig in Guanzhong at normal temperature | |
| US3827942A (en) | Blood agar culture medium | |
| CN111528268B (en) | Meat preservation method based on gas protection | |
| CN103773684A (en) | Method for preserving denitrifying bacteria | |
| CN103773685A (en) | Method for preserving nitrosomas | |
| CN111349573B (en) | High-density fermentation method of saccharomycetes | |
| CN105707203A (en) | Preparing method and application method of preservative for livestock, poultry and fish | |
| Martínez et al. | Combined effect of water activity, pH and additives on growth of Staphylococcus aureus in model salami systems | |
| JPH05308956A (en) | Preservation of nitric acid bacteria and method for restoration | |
| CN114560735B (en) | Biogas slurry bacterial fertilizer and preparation method and application thereof | |
| CN108496962A (en) | A kind of fresh cut-flower antistaling agent | |
| CN111187745A (en) | Preservation method of algae | |
| CN115975882B (en) | Bacillus subtilis and application thereof | |
| NIOH et al. | Growth of bacteria in the heat-killed cell suspensions of the same bacteria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |